HarmonyCa: how a hybrid injectable lifts and stimulates collagen at the same time

De quoi s’agit-il

• A hybrid injectable licensed for sub-dermal placement in the mid-face and along the jawline, delivering the immediate effect of a filler with the biostimulatory effect of calcium hydroxylapatite.
• It suits patients who want lift and skin-quality improvement in one procedure rather than layering treatments over months.

À qui cela s’adresse

• Mid-face descent, flattening cheeks, early jowl formation
• Loss of jawline definition with mild skin laxity
• Patients who want fewer appointments
• Not for lips, tear troughs or very thin superficial skin

Produits utilisés

HarmonyCa and HarmonyCa Lidocaine (Allergan Aesthetics) — CE-approved

Déroulé du traitement

• Facial analysis, marking of the injection vectors and photography.
• Cannula or needle placement in the deep subcutaneous plane.
• Post-injection moulding to the planned contour.

Sécurité

• The calcium hydroxylapatite component is not reversible; depth and plane discipline are essential.
• Only injected by the doctor, in appropriate anatomical zones.

Avant le rendez-vous

Avoid blood thinners where medically allowed; no active infection; plan 5 days before an event.

Soins après le traitement

No massage unless instructed; no gym, sauna or dental work for 48 hours; sleep elevated for two nights.

Résultats et durée

• Immediate lift, a settling phase over 2 weeks, then progressive firmness from week 6 as collagen forms.
• Combined effect commonly lasts 18–24 months.

Effets indésirables et risques possibles

Swelling, bruising, tenderness, nodules if misplaced, rare vascular complications.

Suivi

Review at 6–8 weeks to assess the collagen phase and decide whether a second syringe is needed.

Questions sur ce traitement